The differential expression network of splicing regulator in distinct cancer cells might modulate the impact of Nova1 variants on carcinogenic signature by reprogramming the splicing profiles of Nova1. Nevertheless, the characterization of Nova1-specific candidate is critical for determining its impact in the migration or other carcinogenic signature of CRC. Here, NOVA1 is linked to cancer.